Executive Committee

Leonard Howell
Chair
6/30/2013
Michael A. Nader  Past Chair
6/30/2012
Paul Czoty Sec/Treasurer
6/30/2013
Emily M. Jutkiewicz
Past Sec/Treasurer
6/30/2012
Larry Carter
Councilor
6/30/2014
Wouter Koek
Councilor
6/30/2014
Ellen A. Walker Councilor
6/30/2012
Jeffery M. Witkin Councilor
6/30/2012
Lindsey Hamilton
Postdoctoral Representative
6/30/2012
Michelle Baladi
Predoctoral Representative
6/30/2012
James E. Barrett
 ASPET Council Liaison

Jack Bergman
 Ex officio

Christine K. Carrico Staff Liaison
7/1/2020

 

About the Division...

The Division of Behavioral Pharmacology serves members interested in research on the behavioral effects of drugs. These interests range from behavioral approaches to the study of CNS pharmacology to investigations of how drugs alter behavior and encompass perspectives that range from descriptive to mechanistic. Most often, behavioral pharmacologists examine drugs with an emphasis on effects in the whole organism, and with an appreciation of the considerable influence of environmental variables on drug action. Areas of interest include (but are not limited to): effects of centrally active drugs on conditioned or unconditioned behavior, application of receptor theory to behavioral pharmacology, pharmacological aspects of drug abuse, use of animal models to aid in the discovery and development of new pharmacological agents to treat CNS or psychiatric disorders, drug interactions, the effects of repeated or chronic exposure to drugs, and the use of pharmacological tools in the analysis of behavior.